AU2021230341C8 - Compositions and methods for detecting SARS-CoV-2 nucleic acid - Google Patents
Compositions and methods for detecting SARS-CoV-2 nucleic acidInfo
- Publication number
- AU2021230341C8 AU2021230341C8 AU2021230341A AU2021230341A AU2021230341C8 AU 2021230341 C8 AU2021230341 C8 AU 2021230341C8 AU 2021230341 A AU2021230341 A AU 2021230341A AU 2021230341 A AU2021230341 A AU 2021230341A AU 2021230341 C8 AU2021230341 C8 AU 2021230341C8
- Authority
- AU
- Australia
- Prior art keywords
- seq
- cov
- sars
- target
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2025283673A AU2025283673A1 (en) | 2020-03-04 | 2025-12-22 | Compositions and methods for detecting SARS-CoV-2 nucleic acid |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985139P | 2020-03-04 | 2020-03-04 | |
| US62/985,139 | 2020-03-04 | ||
| US202063010186P | 2020-04-15 | 2020-04-15 | |
| US63/010,186 | 2020-04-15 | ||
| US202063020007P | 2020-05-04 | 2020-05-04 | |
| US63/020,007 | 2020-05-04 | ||
| US202063078790P | 2020-09-15 | 2020-09-15 | |
| US63/078,790 | 2020-09-15 | ||
| PCT/US2021/020839 WO2021178644A1 (en) | 2020-03-04 | 2021-03-04 | Compositions and methods for detecting sars-cov-2 nucleic acid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025283673A Division AU2025283673A1 (en) | 2020-03-04 | 2025-12-22 | Compositions and methods for detecting SARS-CoV-2 nucleic acid |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| AU2021230341A1 AU2021230341A1 (en) | 2022-10-27 |
| AU2021230341B2 AU2021230341B2 (en) | 2025-11-20 |
| AU2021230341C1 AU2021230341C1 (en) | 2026-03-26 |
| AU2021230341C8 true AU2021230341C8 (en) | 2026-05-07 |
Family
ID=75396848
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021230341A Active AU2021230341C8 (en) | 2020-03-04 | 2021-03-04 | Compositions and methods for detecting SARS-CoV-2 nucleic acid |
| AU2025283673A Pending AU2025283673A1 (en) | 2020-03-04 | 2025-12-22 | Compositions and methods for detecting SARS-CoV-2 nucleic acid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025283673A Pending AU2025283673A1 (en) | 2020-03-04 | 2025-12-22 | Compositions and methods for detecting SARS-CoV-2 nucleic acid |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230117369A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4582563A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023516683A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021230341C8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174532A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021178644A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2422956A1 (fr) | 1978-04-13 | 1979-11-09 | Pasteur Institut | Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4868105A (en) | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| JP2641880B2 (ja) | 1986-08-11 | 1997-08-20 | シスカ・ダイアグノスティックス・インコーポレーテッド | 核酸プローブアッセイ法および組成物 |
| US5541308A (en) | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Methods and kits for amplification and testing of nucleic acid sequences |
| IE72468B1 (en) | 1987-07-31 | 1997-04-09 | Univ Leland Stanford Junior | Selective amplification of target polynucleotide sequences |
| US5283174A (en) | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
| US5585481A (en) | 1987-09-21 | 1996-12-17 | Gen-Probe Incorporated | Linking reagents for nucleotide probes |
| WO1989002476A1 (en) | 1987-09-21 | 1989-03-23 | Ml Technology Ventures, L.P. | Homogeneous protection assay |
| US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
| US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
| US5118801A (en) | 1988-09-30 | 1992-06-02 | The Public Health Research Institute | Nucleic acid process containing improved molecular switch |
| US5656207A (en) | 1989-06-24 | 1997-08-12 | Gen Probe Incorporated | Detecting or quantifying multiple analytes using labelling techniques |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| WO1993022461A1 (en) | 1992-05-06 | 1993-11-11 | Gen-Probe Incorporated | Nucleic acid sequence amplification method, composition and kit |
| CA2141430C (en) | 1992-08-04 | 2009-05-12 | Sherrol H. Mcdonough | Nucleic acid sequence amplification |
| JP3026843B2 (ja) | 1993-07-23 | 2000-03-27 | ジェン−プローブ・インコーポレーテッド | 核酸増幅の促進法 |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| EP0709466B1 (en) | 1994-10-28 | 2006-09-27 | Gen-Probe Incorporated | Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences |
| US5731148A (en) | 1995-06-07 | 1998-03-24 | Gen-Probe Incorporated | Adduct protection assay |
| AU713667B2 (en) | 1996-04-12 | 1999-12-09 | Phri Properties, Inc. | Detection probes, kits and assays |
| DK0975807T3 (da) | 1997-05-02 | 2007-01-29 | Gen Probe Inc | To-trins hybridisering og indfangning af et polynukleotid |
| US6534273B2 (en) | 1997-05-02 | 2003-03-18 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| EP1092047B1 (en) | 1998-07-02 | 2009-08-26 | Gen-Probe Incorporated | Molecular torches |
| JP5020818B2 (ja) | 2004-07-01 | 2012-09-05 | ジェン−プローブ・インコーポレーテッド | 生物学的試料中の核酸を検出するための方法及び組成物 |
| CA2898814C (en) | 2004-08-27 | 2015-12-29 | Gen-Probe Incorporated | Single-primer nucleic acid amplification methods |
| AU2006218794A1 (en) | 2005-02-28 | 2006-09-08 | Gen-Probe Incorporated | Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe |
| WO2008016988A1 (en) | 2006-08-01 | 2008-02-07 | Gen-Probe Incorporated | Methods of nonspecific target capture of nucleic acids |
| DK2890814T3 (da) | 2012-08-30 | 2019-12-16 | Gen Probe Inc | Flerfaset nukleinsyreamplificering |
-
2021
- 2021-03-04 AU AU2021230341A patent/AU2021230341C8/en active Active
- 2021-03-04 CA CA3174532A patent/CA3174532A1/en active Pending
- 2021-03-04 WO PCT/US2021/020839 patent/WO2021178644A1/en not_active Ceased
- 2021-03-04 US US17/905,443 patent/US20230117369A1/en active Pending
- 2021-03-04 EP EP25169725.6A patent/EP4582563A3/en active Pending
- 2021-03-04 JP JP2022552805A patent/JP2023516683A/ja active Pending
- 2021-03-04 EP EP21716873.1A patent/EP4114985B1/en active Active
-
2025
- 2025-11-17 JP JP2025196690A patent/JP2026022657A/ja active Pending
- 2025-12-22 AU AU2025283673A patent/AU2025283673A1/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| Corman VM et al, "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", Eurosurveillance, 23 January 2020, 25(3):2000045, doi: 10.2807/1560-7917.ES.2020.25.3.2000045 * |
| WHO TEAM: "Molecular assays to diagnose COVID-19: Summary table of available protocols", 24 January 2020 (2020-01-24), * |
| YINHUA ZHANG ET AL: "Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP", MEDRXIV, 29 February 2020, 2020-02, doi: 10.1101/2020.02.26.20028373 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2025283673A1 (en) | 2026-01-22 |
| EP4114985C0 (en) | 2025-05-07 |
| JP2026022657A (ja) | 2026-02-12 |
| US20230117369A1 (en) | 2023-04-20 |
| CA3174532A1 (en) | 2021-09-10 |
| JP2023516683A (ja) | 2023-04-20 |
| EP4582563A2 (en) | 2025-07-09 |
| EP4114985A1 (en) | 2023-01-11 |
| EP4582563A3 (en) | 2025-10-08 |
| EP4114985B1 (en) | 2025-05-07 |
| AU2021230341B2 (en) | 2025-11-20 |
| AU2021230341C1 (en) | 2026-03-26 |
| WO2021178644A1 (en) | 2021-09-10 |
| AU2021230341A1 (en) | 2022-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240240270A1 (en) | Compositions and methods for detection of viral pathogens in samples | |
| AU2014306512C1 (en) | Compositions and methods for detecting HEV nucleic acid | |
| AU2021230341C1 (en) | Compositions and methods for detecting SARS-CoV-2 nucleic acid | |
| WO2024050540A2 (en) | Compositions and methods for detection of viral pathogens in samples | |
| AU2019314449B2 (en) | Compositions and methods for detecting nucleic acids of Epstein-Barr virus | |
| HK40087028B (en) | Compositions and methods for detecting sars-cov-2 nucleic acid | |
| HK40087028A (en) | Compositions and methods for detecting sars-cov-2 nucleic acid | |
| US20230399708A1 (en) | Compositions and Methods for Detecting Influenza A, Influenza B, and SARS-CoV-2 | |
| US20230082096A1 (en) | Compositions and methods for detecting coronavirus nucleic acid | |
| EP4337797A1 (en) | Compositions and methods for detecting human adenovirus nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20 NOV 2025 |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| TH | Corrigenda |
Free format text: IN VOL 60 , NO 12 , PAGE(S) 1925 UNDER THE HEADING AMENDMENTS - AMENDMENTS MADE PLEASE NOTE THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED SHOULD READ 20 NOV 2025 |